Skip to main content
Journal for Immunotherapy of Cancer logoLink to Journal for Immunotherapy of Cancer
. 2023 Jan 12;11(1):e005414corr1. doi: 10.1136/jitc-2022-005414corr1

Correction: Virtual clinical trials of anti-PD-1 and anti-CTLA-4 immunotherapy in advanced hepatocellular carcinoma using a quantitative systems pharmacology model

PMCID: PMC9843220  PMID: 36634921

Sové RJ, Verma BK, Wang H, et al. Virtual clinical trials of anti-PD-1 and anti-CTLA-4 immunotherapy in advanced hepatocellular carcinoma using a quantitative systems pharmacology model. J ImmunoTher Cancer 2022;10:e005414. doi: 10.1136/jitc-2022-005414.

This article has been corrected since it was first published to indicate that RJS and BKV are joint first authors.


Articles from Journal for Immunotherapy of Cancer are provided here courtesy of BMJ Publishing Group

RESOURCES